Nature Communications (Jun 2016)
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
Abstract
A major goal of HIV-1 vaccine development is to produce antigens that can induce broadly neutralizing antibodies. Here the authors examine the underlying causes of HIV-1 envelope metastability and design uncleaved, prefusion-optimized gp140 trimers with potential for use as HIV-1 vaccine antigens.